Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1953 September; 46(9): 685–700.
PMCID: PMC1918650

Discussion on the Chemotherapy of the Reticuloses

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • GALTON DA. Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953 Jan 31;264(6753):208–213. [PubMed]
  • GARDIKAS C, WILKINSON JF. Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders. Lancet. 1951 Jan 20;1(6647):137–139. [PubMed]
  • WILKINSON JF. Folic acid. Br Med J. 1948 Apr 24;1(4555):771–passim. [PMC free article] [PubMed]
  • WILKINSON JF, GARDIKAS C. Treatment of acute leukemia with aminopterin. Lancet. 1951 Feb 10;1(6650):325–327. [PubMed]
  • KARNOFSKY DA, BURCHENAL JH, ARMISTEAD GC, Jr, SOUTHAM CM, BERNSTEIN JL, CRAVER LF, RHOADS CP. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. [PubMed]
  • NABARRO JDN. Nitrogen mustard therapy with special reference to Hodgkin's disease. Br Med J. 1949 Sep 17;2(4628):622–625. [PMC free article] [PubMed]
  • PATERSON E, BOLAND J. Triaethyleneimino-s-triazine in human malignant disease: a preliminary trial. Br J Cancer. 1951 Mar;5(1):28–37. [PMC free article] [PubMed]
  • ROSE FL, HENDRY JA, WALPOLE AL. New cytotoxic agents with tumour-inhibitory activity. Nature. 1950 Jun 24;165(4208):993–996. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press